Page last updated: 2024-09-04

pralnacasan and Body Weight

pralnacasan has been researched along with Body Weight in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gerwin, N; Rudolphi, K; van den Berg, W; van der Kraan, P; Verzijl, N	1

Other Studies

1 other study(ies) available for pralnacasan and Body Weight

Article	Year
Pralnacasan, an inhibitor of interleukin-1beta converting enzyme, reduces joint damage in two murine models of osteoarthritis. Osteoarthritis and cartilage, 2003, Volume: 11, Issue:10 Topics: Amino Acids; Animals; Anti-Inflammatory Agents; Azepines; Body Weight; Caspase Inhibitors; Collagen; Disease Models, Animal; Eating; Female; Hindlimb; Isoquinolines; Joints; Male; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Osteoarthritis, Knee; Pyridazines	2003

Article

Year

Pralnacasan, an inhibitor of interleukin-1beta converting enzyme, reduces joint damage in two murine models of osteoarthritis.

Osteoarthritis and cartilage, 2003, Volume: 11, Issue:10

Topics: Amino Acids; Animals; Anti-Inflammatory Agents; Azepines; Body Weight; Caspase Inhibitors; Collagen; Disease Models, Animal; Eating; Female; Hindlimb; Isoquinolines; Joints; Male; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Osteoarthritis, Knee; Pyridazines

2003